PHADECODE XA INHIBITOR ASSAY— 510(k) K792019

Substantially Equivalent

Pharmaseal Div., Baxter Healthcare Corp.

FDA 510(k) clearance K792019 for PHADECODE XA INHIBITOR ASSAY, Substantially Equivalent on 1979-11-05. Applicant: Pharmaseal Div., Baxter Healthcare Corp..

Clearance details

Applicant: Pharmaseal Div., Baxter Healthcare Corp.
Product code: Code JBQ
Advisory panel: Hematology
Date received: 1979-10-09
Decision date: 1979-11-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.